Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 25770771)

  • 1. Doxorubicin and curcumin co-delivery by lipid nanoparticles for enhanced treatment of diethylnitrosamine-induced hepatocellular carcinoma in mice.
    Zhao X; Chen Q; Li Y; Tang H; Liu W; Yang X
    Eur J Pharm Biopharm; 2015 Jun; 93():27-36. PubMed ID: 25770771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Codelivery of doxorubicin and curcumin with lipid nanoparticles results in improved efficacy of chemotherapy in liver cancer.
    Zhao X; Chen Q; Liu W; Li Y; Tang H; Liu X; Yang X
    Int J Nanomedicine; 2015; 10():257-70. PubMed ID: 25565818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-assembly of doxorubicin and curcumin targeted micelles for synergistic delivery and improving anti-tumor efficacy.
    Ma W; Guo Q; Li Y; Wang X; Wang J; Tu P
    Eur J Pharm Biopharm; 2017 Mar; 112():209-223. PubMed ID: 27913127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo evaluation of a new polymer-lipid hybrid nanoparticle (PLN) formulation of doxorubicin in a murine solid tumor model.
    Wong HL; Rauth AM; Bendayan R; Wu XY
    Eur J Pharm Biopharm; 2007 Mar; 65(3):300-8. PubMed ID: 17156986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increase of doxorubicin sensitivity by doxorubicin-loading into nanoparticles for hepatocellular carcinoma cells in vitro and in vivo.
    Barraud L; Merle P; Soma E; Lefrançois L; Guerret S; Chevallier M; Dubernet C; Couvreur P; Trépo C; Vitvitski L
    J Hepatol; 2005 May; 42(5):736-43. PubMed ID: 15826724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous delivery of doxorubicin and GG918 (Elacridar) by new polymer-lipid hybrid nanoparticles (PLN) for enhanced treatment of multidrug-resistant breast cancer.
    Wong HL; Bendayan R; Rauth AM; Wu XY
    J Control Release; 2006 Dec; 116(3):275-84. PubMed ID: 17097178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-delivery of doxorubicin and curcumin by pH-sensitive prodrug nanoparticle for combination therapy of cancer.
    Zhang Y; Yang C; Wang W; Liu J; Liu Q; Huang F; Chu L; Gao H; Li C; Kong D; Liu Q; Liu J
    Sci Rep; 2016 Feb; 6():21225. PubMed ID: 26876480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation of poly-l-lysine-based nanoparticles with pH-sensitive release of curcumin for targeted imaging and therapy of liver cancer in vitro and in vivo.
    Yang DH; Kim HJ; Park K; Kim JK; Chun HJ
    Drug Deliv; 2018 Nov; 25(1):950-960. PubMed ID: 29658319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanomicelles loaded with doxorubicin and curcumin for alleviating multidrug resistance in lung cancer.
    Gu Y; Li J; Li Y; Song L; Li D; Peng L; Wan Y; Hua S
    Int J Nanomedicine; 2016; 11():5757-5770. PubMed ID: 27843316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel doxorubicin-mitomycin C co-encapsulated nanoparticle formulation exhibits anti-cancer synergy in multidrug resistant human breast cancer cells.
    Shuhendler AJ; Cheung RY; Manias J; Connor A; Rauth AM; Wu XY
    Breast Cancer Res Treat; 2010 Jan; 119(2):255-69. PubMed ID: 19221875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A mechanistic study of enhanced doxorubicin uptake and retention in multidrug resistant breast cancer cells using a polymer-lipid hybrid nanoparticle system.
    Wong HL; Bendayan R; Rauth AM; Xue HY; Babakhanian K; Wu XY
    J Pharmacol Exp Ther; 2006 Jun; 317(3):1372-81. PubMed ID: 16547167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Albumin-Albumin/Lactosylated Core-Shell Nanoparticles: Therapy to Treat Hepatocellular Carcinoma for Controlled Delivery of Doxorubicin.
    Teran-Saavedra NG; Sarabia-Sainz JA; Velázquez-Contreras EF; Ramos-Clamont Montfort G; Pedroza-Montero M; Vazquez-Moreno L
    Molecules; 2020 Nov; 25(22):. PubMed ID: 33233564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beneficial effect of cepharanthine on overcoming drug-resistance of hepatocellular carcinoma.
    Nakajima A; Yamamoto Y; Taura K; Hata K; Fukumoto M; Uchinami H; Yonezawa K; Yamaoka Y
    Int J Oncol; 2004 Mar; 24(3):635-45. PubMed ID: 14767548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyvinylpyrrolidone Assisted One-Pot Synthesis of Size-Tunable Cocktail Nanodrug for Multifunctional Combat of Cancer.
    Wang C; Pan J; Chen S; Qiu L; Hu H; Ji L; Wang J; Liu W; Ni X
    Int J Nanomedicine; 2024; 19():4339-4356. PubMed ID: 38774026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surfactant-polymer nanoparticles: a novel platform for sustained and enhanced cellular delivery of water-soluble molecules.
    Chavanpatil MD; Khdair A; Panyam J
    Pharm Res; 2007 Apr; 24(4):803-10. PubMed ID: 17318416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new polymer-lipid hybrid nanoparticle system increases cytotoxicity of doxorubicin against multidrug-resistant human breast cancer cells.
    Wong HL; Rauth AM; Bendayan R; Manias JL; Ramaswamy M; Liu Z; Erhan SZ; Wu XY
    Pharm Res; 2006 Jul; 23(7):1574-85. PubMed ID: 16786442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced cytotoxicity of core modified chitosan based polymeric micelles for doxorubicin delivery.
    Ye YQ; Chen FY; Wu QA; Hu FQ; Du YZ; Yuan H; Yu HY
    J Pharm Sci; 2009 Feb; 98(2):704-12. PubMed ID: 18563810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiotherapy-induced enrichment of EGF-modified doxorubicin nanoparticles enhances the therapeutic outcome of lung cancer.
    Wang J; Zhang Y; Zhang G; Xiang L; Pang H; Xiong K; Lu Y; Li J; Dai J; Lin S; Fu S
    Drug Deliv; 2022 Dec; 29(1):588-599. PubMed ID: 35156493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design of smart chemotherapy of doxorubicin hydrochloride using nanostructured lipid carriers and solid lipid nanoparticles for improved anticancer efficacy.
    Yeo S; Wu H; Yoon I; Lee WK; Hwang SJ
    Int J Pharm; 2024 May; 657():124048. PubMed ID: 38537925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-Treatments of Edible Curcumin from Turmeric Rhizomes and Chemotherapeutic Drugs on Cytotoxicity and FLT3 Protein Expression in Leukemic Stem Cells.
    Chueahongthong F; Tima S; Chiampanichayakul S; Berkland C; Anuchapreeda S
    Molecules; 2021 Sep; 26(19):. PubMed ID: 34641328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.